Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001062993-11-003085
Filing Date
2011-08-02
Accepted
2011-08-02 12:16:24
Documents
9
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT FOR THE PERIOD ENDED JUNE 30, 2011 form10q.htm 10-Q 304609
2 SECTION 302 CERTIFICATION exhibit31-1.htm EX-31.1 7107
3 SECTION 906 CERTIFICATION exhibit32-1.htm EX-32.1 2463
  Complete submission text file 0001062993-11-003085.txt   1616014

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT alrx-20110630.xml EX-101.INS 160830
5 XBRL TAXONOMY SCHEMA alrx-20110630.xsd EX-101.SCH 15488
6 XBRL TAXONOMY CALCULATION LINKBASE alrx-20110630_cal.xml EX-101.CAL 29247
7 XBRL TAXONOMY DEFINITION LINKBASE alrx-20110630_def.xml EX-101.DEF 92859
8 XBRL TAXONOMY LABEL LINKBASE alrx-20110630_lab.xml EX-101.LAB 125526
9 XBRL TAXONOMY PRESENTATION LINKBASE alrx-20110630_pre.xml EX-101.PRE 103056
Mailing Address 168 KONRAD CRESCENT SUITE 200 MARKHAM A6 V6E2K3
Business Address 168 KONRAD CRESCENT SUITE 200 MARKHAM A6 V6E2K3 (905) 479-3245
ALPHARX INC (Filer) CIK: 0001114936 (see all company filings)

EIN.: 980177440 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-30813 | Film No.: 111002735
SIC: 2834 Pharmaceutical Preparations